Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

COUCH Medcomms

- PMLiVE

Genzyme shocked by FDA’s rejection of Lemtrada

US regulator refuses to approve MS drug on safety grounds

- PMLiVE

Takeda pipeline hit by fasiglifam failure

Diabetes candidate had been set for a 2015 launch

- PMLiVE

Community research

Leveraging ‘controlled’ social web environments to garner healthcare business insights

- PMLiVE

US approval for Novo’s Factor XIII drug Tretten

Becomes first recombinant treatment licensed for a rare clotting disorder

2013: pharma’s year of mobile?

Industry use of the technology stepped up a gear this year

- PMLiVE

CHMP backs Piramal’s Alzheimer’s imaging agent

Neuraceq recommended for approval in Europe

- PMLiVE

Lions Health awards open for entry

Creativity in health festival makes its debut next year

- PMLiVE

PharmApprove appoints Solvay’s Coos De Graaf

He will to lead the agency's new European office

- PMLiVE

The oncology market in Canada

Ten per cent is not enough - simple estimates of the Canadian oncology market overlook a complex picture

EU flag

MEPs agree clinical trial regulation revision

Paves way for EU trial database and simplified online applications for new studies

- PMLiVE

Janssen’s Sirturo wins backing for conditional EU licence

CHMP recommends first-in-class multidrug-resistant tuberculosis treatment

- PMLiVE

Cegedim’s physician network Docnet set for US debut

Online healthcare professional community will have phased launch from 2014

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links